Palboxen 125 mg - Palbociclib - Ibrance - Aio Pharma

Palboxen 125 mg (Palbociclib) sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of breast cancer.


Who Upvoted this Story


Comments